Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roger Bedimo

Showing results (71-80 of 88) with videos related to

Pageof 9
Sort By:
Contemporary Clinical Trials|May 25, 2023
Contingency management with stepped care for unhealthy alcohol use among individuals with HIV: Protocol for a randomized controlled trialE Jennifer Edelman, James Dziura, Yanhong Deng, et al.
JAMA|December 1, 2022
Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults: 2022 Recommendations of the International Antiviral Society-USA PanelRajesh T Gandhi, Roger Bedimo, Jennifer F Hoy, et al.
Open Forum Infectious Diseases|April 10, 2025
Cardiovascular Hazards of Abacavir- Versus Tenofovir-Containing Antiretroviral Therapies: Insights From an Analysis of the REPRIEVE Trial CohortEmma Davies Smith, Carlos Malvestutto, Heather J Ribaudo, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|January 15, 2015
HIV infection, cardiovascular disease risk factor profile, and risk for acute myocardial infarctionAnne-Lise Paisible, Chung-Chou H Chang, Kaku A So-Armah, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 20, 2014
MSG-01: A randomized, double-blind, placebo-controlled trial of caspofungin prophylaxis followed by preemptive therapy for invasive candidiasis in high-risk adults in the critical care settingLuis Ostrosky-Zeichner, Shmuel Shoham, Jose Vazquez, et al.
Open Forum Infectious Diseases|July 24, 2023
Early Outcomes of SARS-CoV-2 Infection in a Multisite Prospective Cohort of Inpatient VeteransJennifer M Ross, Jonathan D Sugimoto, Andrew Timmons, et al.
Biomed Research International|February 18, 2015
CD8+ T-cells count in acute myocardial infarction in HIV disease in a predominantly male cohortOluwatosin A Badejo, Chung-Chou Chang, Kaku A So-Armah, et al.
The Lancet. HIV|April 3, 2025
Statin effects on the incidence of major non-cardiovascular disease events among a global cohort of people with HIV: a randomised controlled trialMarissa R Diggs, Triin Umbleja, Sara McCallum, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 29, 2024
2024 Clinical Practice Guideline Update by the Infectious Diseases Society of America on the Management of COVID-19: Anti-SARS-CoV-2 Neutralizing Antibody Pemivibart for Pre-exposure ProphylaxisAdarsh Bhimraj, Yngve Falck-Ytter, Arthur Y Kim, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 26, 2025
Factors Affecting Risk of CVD Events in a Global CVD Prevention Cohort of People with HIVSteven K Grinspoon, Maya Watanabe, Heather J Ribaudo, et al.
Pageof 9

Showing results (71-80 of 88) with videos related to

Sort By:
Pageof 9
Contemporary Clinical Trials|May 25, 2023
Contingency management with stepped care for unhealthy alcohol use among individuals with HIV: Protocol for a randomized controlled trialE Jennifer Edelman, James Dziura, Yanhong Deng, et al.
JAMA|December 1, 2022
Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults: 2022 Recommendations of the International Antiviral Society-USA PanelRajesh T Gandhi, Roger Bedimo, Jennifer F Hoy, et al.
Open Forum Infectious Diseases|April 10, 2025
Cardiovascular Hazards of Abacavir- Versus Tenofovir-Containing Antiretroviral Therapies: Insights From an Analysis of the REPRIEVE Trial CohortEmma Davies Smith, Carlos Malvestutto, Heather J Ribaudo, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|January 15, 2015
HIV infection, cardiovascular disease risk factor profile, and risk for acute myocardial infarctionAnne-Lise Paisible, Chung-Chou H Chang, Kaku A So-Armah, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 20, 2014
MSG-01: A randomized, double-blind, placebo-controlled trial of caspofungin prophylaxis followed by preemptive therapy for invasive candidiasis in high-risk adults in the critical care settingLuis Ostrosky-Zeichner, Shmuel Shoham, Jose Vazquez, et al.
Open Forum Infectious Diseases|July 24, 2023
Early Outcomes of SARS-CoV-2 Infection in a Multisite Prospective Cohort of Inpatient VeteransJennifer M Ross, Jonathan D Sugimoto, Andrew Timmons, et al.
Biomed Research International|February 18, 2015
CD8+ T-cells count in acute myocardial infarction in HIV disease in a predominantly male cohortOluwatosin A Badejo, Chung-Chou Chang, Kaku A So-Armah, et al.
The Lancet. HIV|April 3, 2025
Statin effects on the incidence of major non-cardiovascular disease events among a global cohort of people with HIV: a randomised controlled trialMarissa R Diggs, Triin Umbleja, Sara McCallum, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 29, 2024
2024 Clinical Practice Guideline Update by the Infectious Diseases Society of America on the Management of COVID-19: Anti-SARS-CoV-2 Neutralizing Antibody Pemivibart for Pre-exposure ProphylaxisAdarsh Bhimraj, Yngve Falck-Ytter, Arthur Y Kim, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 26, 2025
Factors Affecting Risk of CVD Events in a Global CVD Prevention Cohort of People with HIVSteven K Grinspoon, Maya Watanabe, Heather J Ribaudo, et al.
Pageof 9